TAK - TAKEDA PHARMACEUTICAL CO LTD
17.76
-0.460 -2.590%
Share volume: 2,715,804
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$18.22
-0.46
-0.03%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | |
| Report Date | 07-27-2023 | 10-30-2023 | |
| Cash flow financing | -399.279 M | -929.136 M | |
| Other financing cash flows | 0.000 | 0.000 | |
| Cash flow | 638.529 M | 1.312 B | |
| Net income | 617.770 M | -321.540 M | |
| Depreciation | 1.185 B | 1.186 B | |
| Changes in inventories | 7.487 B | 7.738 B | |
| Changes in receivables | 5.705 B | 5.276 B | |
| Investing Cashflow | -1.842 B | -347.978 M | |
| Net Borrowings | 34.608 B | 33.805 B | |
| Investing Activity Other | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | |
| Capital Expenditures | -1.861 B | -410.751 M | |
| Cash Change | 2.186 B | 2.129 B |